Ivermectina para COVID-19 (18 feb. 2021) Instituto de Efectividad Clínica y Sanitaria. Publication year: 2021 Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Betacoronavirus/drug effects, Ivermectin/therapeutic use, Technology Assessment, Biomedical, Health Evaluation, Cost-Benefit Analysis Fulltext